Proteinases in cardiovascular aneurysms and rupture: targets for therapy?
Carmeliet
P
P
The Center for Transgene Technology and Gene Therapy, Flanders Interuniversity Institute for Biotechnology, KU Leuven, Leuven, Belgium. peter.carmeliet@med.kuleuven.ac.be
D000818:Animals; D017544:Aortic Aneurysm, Abdominal / Q000517:prevention & control*; D018390:Gene Targeting; D020780:Matrix Metalloproteinase 9 / Q000235:genetics* / Q000502:physiology; D051379:Mice
D020780:Matrix Metalloproteinase 9